Market Readiness
Published 2026-08-26 · 5 named sources
How to Brief UFI and Poison-Centre Data for an EU Toilet Cleaner
An EU toilet-cleaner brief should assign notification ownership, lock the formula-to-UFI link and align label, market and poison-centre data before launch.
A UFI printed on a toilet-cleaner label can look like a small artwork detail, but it represents a controlled link between a mixture composition and information supplied for emergency health response. It should not be added at the end of label design without checking the finished formula, hazard classification, legal entity, markets and notification status.
For an OEM project, the useful question is not simply “Can the factory provide a UFI?” The buyer, EU importer, manufacturer and regulatory adviser need to agree who holds each obligation, what information is fixed, and which changes will trigger review before the product is placed on a market.
Start with the finished mixture and intended markets
The EU Classification, Labelling and Packaging Regulation, or CLP, governs classification, labelling and packaging of chemical mixtures. Article 45 and Annex VIII establish harmonised information requirements for emergency health response. Those requirements concern mixtures classified for relevant health or physical hazards; a product name, acid family or alkaline direction alone does not determine the final obligation.
That distinction matters for toilet cleaners. An acidic descaling direction and a sodium-hypochlorite direction are separate formulation projects and must never be mixed, but neither name is a substitute for classifying the finished mixture. The final composition, concentration ranges, supplied raw-material information and intended use must be assessed before the team decides what notification and label work applies.
The market list also belongs at the start of the brief. The Irish Health and Safety Authority states that notification is required to the appointed body in each Member State where an in-scope hazardous mixture is placed on the market, with market language and national arrangements considered. A single “EU label” assumption can therefore miss destination-specific data, language or fee decisions.
Assign the duty holder before generating codes
A non-EU OEM manufacturer can organise formula and product data, but it should not casually present itself as the EU duty holder. The HSA explains that non-EU suppliers are not duty holders under CLP and cannot themselves fulfil the poison-centre obligation; they can support an EU customer with the necessary information or use an agreed EU-based legal entity in a voluntary supply-chain arrangement.
The current brief should identify the EU importer or other responsible entity, the product names it will place on each market, and whether any distributor will rebrand, relabel or introduce the mixture into additional Member States. This is a legal-role question, not a branding preference. National authority guidance should be checked for the planned launch countries, and specialist advice may be appropriate where the supply chain is unusual.
Great Britain also needs a separate decision. UK government guidance says there is no UFI obligation under GB CLP, while EU CLP Annex VIII applies in Northern Ireland. Treating “UK” as one notification route can therefore produce the wrong artwork or submission plan.
Keep one UFI linked to one controlled composition
The HSA describes the UFI as a product-specific code included in the notification and affixed to the label, while the submitted composition data identifies the associated mixture. Products carrying the same UFI must remain within the applicable composition rules. The code must appear with the prefix “UFI:” and be visible and legible where required; printing a plausible-looking code is not enough.
The UFI should be generated from a controlled formulation number under the selected legal entity's system, then recorded with the exact product and market data used in the notification. Germany's BfR guidance notes that significant composition changes require a new UFI and corresponding notification treatment. That makes formula revision control part of artwork control.
A fragrance adjustment, colour change, raw-material substitution or concentration movement should therefore enter the project's regulatory change review. The outcome is not always “new UFI,” because the legal criteria and permitted concentration treatment must be applied to the actual case. The important control is that a commercial change cannot bypass the regulatory owner.
Build the PCN dataset beside the product brief
The poison-centre notification is more than a code. HSA's information sheet lists data including notifier identity, trade names, packaging type and size, product category, UFI, hazard classification, toxicological information, physicochemical properties and composition information. The information must be prepared in the EU-harmonised PCN format for submission through the applicable route.
For a toilet-cleaner OEM project, those fields connect several workstreams. The commercial team confirms names, markets, pack sizes and intended uses. The formulation team controls composition and raw-material identity. The packaging team confirms actual container and nominal volume. The regulatory owner establishes classification, label elements and submission data. If these teams use different product names, sizes or formula versions, the UFI cannot repair the mismatch.
The PCN dataset should also be versioned with the SDS and approved label master. A submission receipt should not be described as product approval: UK government guidance expressly notes that poison-service submission does not itself approve a product for sale. Other applicable detergent, packaging and market rules remain separate.
Make artwork release conditional on notification readiness
Label artwork can progress before the submission is complete, but release for printing should include a controlled UFI checkpoint. The Annex VIII framework connects the UFI shown on an in-scope product with the submitted mixture information. The project record should therefore connect the verified UFI, legal entity, formula version, product identifiers, destination markets, notification status and final artwork proof before market placement.
This checkpoint is useful for both an [existing 1 kg toilet-gel packaging route](/products/glycolic-acid-toilet-gel-1kg) and a new pack. Existing packaging can shorten physical development, but it does not remove formula classification or market-notification work. A private mould can add more artwork and pack testing time, yet the same formula-to-UFI control remains necessary.
Turn the requirement into an OEM handover
Before sampling or artwork release, an EU toilet-cleaner brief should answer six questions: Which finished formula version is being assessed? Which entity is the duty holder? Which countries and languages are in scope? Which trade names and pack sizes will be notified? Who generates and controls the UFI? Which changes reopen classification, notification or artwork review?
EPHYON can coordinate formula, pack and project records through its [toilet-cleaner OEM process](/toilet-cleaner-oem), while the buyer and its appointed regulatory specialists retain the market decisions appropriate to their legal roles. Supporting factory and documentation context is available on the [certificates and verification page](/certificates). Buyers preparing an EU launch can [send the target markets, legal entity and proposed pack route in the enquiry brief](/contact?route=oem&source=news&article=eu-ufi-poison-centre-toilet-cleaner-brief).
Sources
These sources support the general guidance above. They do not certify EPHYON or a proposed product.
- 01Regulation (EC) No 1272/2008 on classification, labelling and packaging — consolidated text
EUR-Lex · 2026-07-01 · Accessed 2026-08-26
- 02Poison Centre Notifications for Hazardous Chemical Mixtures in Ireland — Information Sheet
Health and Safety Authority, Ireland · 2025 · Accessed 2026-08-26
- 03Questions and Answers on the Notification of Dangerous Products for Emergency Medical Care in Germany
German Federal Institute for Risk Assessment (BfR) · 2024-08-07 · Accessed 2026-08-26
- 04Classification and labelling (CLP/GHS)
European Commission · Accessed 2026-08-26
- 05Submitting chemicals information to the National Poisons Information Service
UK Department of Health and Social Care · 2021-05-24 · Accessed 2026-08-26